Seritage Growth [SRG] vs CBRE [CBRE] Detailed Stock Comparison
Seritage Growth
NYSE
Loading...
CBRE
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Seritage Growth wins in 9 metrics, CBRE wins in 10 metrics, with 0 ties. CBRE appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Seritage Growth | CBRE | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.02 | 43.85 | Seritage Growth |
| Price-to-Book Ratio | 0.43 | 5.48 | Seritage Growth |
| Debt-to-Equity Ratio | 62.75 | 108.18 | Seritage Growth |
| PEG Ratio | 1.33 | 25.73 | Seritage Growth |
| EV/EBITDA | -4.81 | 22.68 | Seritage Growth |
| Profit Margin (TTM) | -15.05% | 2.86% | CBRE |
| Operating Margin (TTM) | 282.85% | 3.64% | Seritage Growth |
| EBITDA Margin (TTM) | 282.85% | 3.64% | Seritage Growth |
| Return on Equity | -33.85% | 12.95% | CBRE |
| Return on Assets (TTM) | -5.97% | 4.01% | CBRE |
| Free Cash Flow (TTM) | $-53.55M | $1.40B | CBRE |
| 1-Year Return | -38.15% | 42.45% | CBRE |
| Price-to-Sales Ratio (TTM) | -48.68 | 1.22 | Seritage Growth |
| Enterprise Value | $310.45M | $54.32B | CBRE |
| EV/Revenue Ratio | -90.96 | 1.43 | Seritage Growth |
| Gross Profit Margin (TTM) | 16.05% | 18.58% | CBRE |
| Revenue per Share (TTM) | $0 | $126 | CBRE |
| Earnings per Share (Diluted) | $-2.83 | $3.52 | CBRE |
| Beta (Stock Volatility) | 2.49 | 1.35 | CBRE |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Seritage Growth vs CBRE Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Seritage Growth | -1.03% | -6.82% | -4.65% | -2.71% | -19.61% | -31.01% |
| CBRE | 0.67% | 0.95% | 11.09% | 23.80% | 8.02% | 19.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Seritage Growth | -38.15% | -79.50% | -77.44% | -92.96% | -92.35% | -92.35% |
| CBRE | 42.45% | 77.90% | 237.83% | 306.67% | 862.66% | 877.80% |
Performance & Financial Health Analysis: Seritage Growth vs CBRE
| Metric | SRG | CBRE |
|---|---|---|
| Market Information | ||
| Market Cap | $166.16M | $46.38B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 125,760 | 2,188,070 |
| 90 Day Avg. Volume | 98,093 | 1,653,517 |
| Last Close | $2.87 | $155.40 |
| 52 Week Range | $2.43 - $4.84 | $106.27 - $161.03 |
| % from 52W High | -40.76% | -3.50% |
| All-Time High | $57.31 (Apr 11, 2016) | $161.05 (Jul 29, 2025) |
| % from All-Time High | -94.99% | -3.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.16% |
| Quarterly Earnings Growth | -0.20% | 0.65% |
| Financial Health | ||
| Profit Margin (TTM) | -0.15% | 0.03% |
| Operating Margin (TTM) | 2.83% | 0.04% |
| Return on Equity (TTM) | -0.34% | 0.13% |
| Debt to Equity (MRQ) | 62.75 | 108.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.77 | $28.16 |
| Cash per Share (MRQ) | $1.67 | $4.76 |
| Operating Cash Flow (TTM) | $-46,117,000 | $1.42B |
| Levered Free Cash Flow (TTM) | $20.38M | $640.88M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Seritage Growth vs CBRE
| Metric | SRG | CBRE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.02 | 43.85 |
| Forward P/E | 1.33 | 25.73 |
| PEG Ratio | 1.33 | 25.73 |
| Price to Sales (TTM) | -48.68 | 1.22 |
| Price to Book (MRQ) | 0.43 | 5.48 |
| Market Capitalization | ||
| Market Capitalization | $166.16M | $46.38B |
| Enterprise Value | $310.45M | $54.32B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -90.96 | 1.43 |
| Enterprise to EBITDA | -4.81 | 22.68 |
| Risk & Other Metrics | ||
| Beta | 2.49 | 1.35 |
| Book Value per Share (MRQ) | $6.77 | $28.16 |
Financial Statements Comparison: Seritage Growth vs CBRE
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SRG | CBRE |
|---|---|---|
| Revenue/Sales | $4.60M | $8.91B |
| Cost of Goods Sold | $3.86M | $7.27B |
| Gross Profit | $738,000 | $1.65B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-17.03M | $276.00M |
| EBITDA | $-21.98M | $453.00M |
| Pre-Tax Income | $-22.39M | $243.00M |
| Income Tax | $-190,000 | $52.00M |
| Net Income (Profit) | $-22.20M | $191.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SRG | CBRE |
|---|---|---|
| Cash & Equivalents | $94.27M | $1.38B |
| Total Current Assets | $123.10M | $10.83B |
| Total Current Liabilities | $27.25M | $10.87B |
| Long-Term Debt | $240.00M | $5.15B |
| Total Shareholders Equity | $382.45M | $8.63B |
| Retained Earnings | $-982.21M | $9.39B |
| Property, Plant & Equipment | N/A | $4.74B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SRG | CBRE |
|---|---|---|
| Operating Cash Flow | $-19.11M | $329.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-9.19M | $-610.00M |
| Debt Repayment | $0 | $-165.00M |
| Common Stock Repurchase | N/A | $-418.00M |
Short Interest & Institutional Ownership Analysis
| Metric | SRG | CBRE |
|---|---|---|
| Shares Short | 5.75M | 3.69M |
| Short Ratio | 57.09 | 2.62 |
| Short % of Float | 0.14% | 0.01% |
| Average Daily Volume (10 Day) | 125,760 | 2,188,070 |
| Average Daily Volume (90 Day) | 98,093 | 1,653,517 |
| Shares Outstanding | 56.27M | 302.05M |
| Float Shares | 37.79M | 290.91M |
| % Held by Insiders | 0.41% | 0.01% |
| % Held by Institutions | 0.49% | 1.00% |
Dividend Analysis & Yield Comparison: Seritage Growth vs CBRE
| Metric | SRG | CBRE |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |